Delayed
Japan Exchange
10:23:40 26/06/2024 am IST
|
5-day change
|
1st Jan Change
|
2,886
JPY
|
+0.73%
|
|
+0.21%
|
+6.02%
|
Fiscal Period: February |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
43,804
|
50,614
|
48,008
|
47,616
|
56,825
|
56,140
|
-
|
-
|
Enterprise Value (EV)
1 |
50,254
|
57,778
|
59,367
|
58,085
|
65,469
|
56,140
|
56,140
|
56,140
|
P/E ratio
|
14
x
|
15.4
x
|
16.2
x
|
14.7
x
|
14.9
x
|
13.7
x
|
12.8
x
|
-
|
Yield
|
0.99%
|
0.9%
|
0.99%
|
1.03%
|
0.9%
|
0.98%
|
1.05%
|
-
|
Capitalization / Revenue
|
0.43
x
|
0.46
x
|
0.4
x
|
0.37
x
|
0.4
x
|
0.38
x
|
0.36
x
|
-
|
EV / Revenue
|
0.43
x
|
0.46
x
|
0.4
x
|
0.37
x
|
0.4
x
|
0.38
x
|
0.36
x
|
-
|
EV / EBITDA
|
7.14
x
|
6.88
x
|
7.24
x
|
6.38
x
|
7.08
x
|
6.24
x
|
5.85
x
|
-
|
EV / FCF
|
-
|
66.7
x
|
-16.4
x
|
23.3
x
|
16.4
x
|
20.3
x
|
16.9
x
|
19.4
x
|
FCF Yield
|
-
|
1.5%
|
-6.11%
|
4.29%
|
6.1%
|
4.93%
|
5.91%
|
5.17%
|
Price to Book
|
1.98
x
|
2.02
x
|
1.74
x
|
1.59
x
|
1.71
x
|
1.52
x
|
1.38
x
|
-
|
Nbr of stocks (in thousands)
|
19,740
|
19,740
|
19,740
|
19,595
|
19,595
|
19,595
|
-
|
-
|
Reference price
2 |
2,219
|
2,564
|
2,432
|
2,430
|
2,900
|
2,865
|
2,865
|
2,865
|
Announcement Date
|
06/04/20
|
05/04/21
|
05/04/22
|
05/04/23
|
05/04/24
|
-
|
-
|
-
|
Fiscal Period: February |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
1,02,017
|
1,10,535
|
1,20,310
|
1,28,791
|
1,42,241
|
1,49,000
|
1,58,000
|
-
|
EBITDA
1 |
6,138
|
7,362
|
6,634
|
7,462
|
8,028
|
9,000
|
9,600
|
-
|
EBIT
1 |
3,914
|
4,976
|
4,043
|
4,660
|
5,209
|
6,100
|
6,600
|
-
|
Operating Margin
|
3.84%
|
4.5%
|
3.36%
|
3.62%
|
3.66%
|
4.09%
|
4.18%
|
-
|
Earnings before Tax (EBT)
1 |
4,312
|
4,682
|
4,042
|
4,722
|
5,292
|
6,200
|
6,700
|
-
|
Net income
1 |
3,122
|
3,290
|
2,964
|
3,240
|
3,825
|
4,100
|
4,400
|
-
|
Net margin
|
3.06%
|
2.98%
|
2.46%
|
2.52%
|
2.69%
|
2.75%
|
2.78%
|
-
|
EPS
2 |
158.2
|
166.7
|
150.2
|
165.0
|
195.2
|
209.2
|
224.5
|
-
|
Free Cash Flow
1 |
-
|
759
|
-2,935
|
2,042
|
3,467
|
2,770
|
3,320
|
2,900
|
FCF margin
|
-
|
0.69%
|
-2.44%
|
1.59%
|
2.44%
|
1.86%
|
2.1%
|
-
|
FCF Conversion (EBITDA)
|
-
|
10.31%
|
-
|
27.37%
|
43.19%
|
30.78%
|
34.58%
|
-
|
FCF Conversion (Net income)
|
-
|
23.07%
|
-
|
63.02%
|
90.64%
|
67.56%
|
75.45%
|
-
|
Dividend per Share
2 |
22.00
|
23.00
|
24.00
|
25.00
|
26.00
|
28.00
|
30.00
|
-
|
Announcement Date
|
06/04/20
|
05/04/21
|
05/04/22
|
05/04/23
|
05/04/24
|
-
|
-
|
-
|
Fiscal Period: February |
2021 S1
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
56,764
|
60,302
|
29,775
|
30,233
|
30,952
|
33,731
|
64,683
|
32,119
|
31,989
|
33,778
|
37,764
|
71,542
|
35,315
|
35,384
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
3,057
|
2,647
|
913
|
483
|
1,223
|
1,599
|
2,822
|
1,212
|
626
|
1,350
|
1,919
|
3,269
|
1,390
|
550
|
Operating Margin
|
5.39%
|
4.39%
|
3.07%
|
1.6%
|
3.95%
|
4.74%
|
4.36%
|
3.77%
|
1.96%
|
4%
|
5.08%
|
4.57%
|
3.94%
|
1.55%
|
Earnings before Tax (EBT)
|
2,817
|
2,795
|
1,005
|
-
|
1,305
|
-
|
2,986
|
1,320
|
-
|
1,441
|
-
|
3,358
|
1,534
|
-
|
Net income
1 |
1,943
|
2,084
|
712
|
168
|
894
|
1,166
|
2,060
|
914
|
266
|
984
|
1,305
|
2,289
|
1,062
|
474
|
Net margin
|
3.42%
|
3.46%
|
2.39%
|
0.56%
|
2.89%
|
3.46%
|
3.18%
|
2.85%
|
0.83%
|
2.91%
|
3.46%
|
3.2%
|
3.01%
|
1.34%
|
EPS
|
98.47
|
105.6
|
36.04
|
-
|
45.33
|
-
|
104.6
|
46.64
|
-
|
50.23
|
-
|
116.9
|
54.20
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/10/20
|
05/10/21
|
05/01/22
|
05/04/22
|
05/07/22
|
05/10/22
|
05/10/22
|
06/01/23
|
05/04/23
|
05/07/23
|
05/10/23
|
05/10/23
|
05/01/24
|
05/04/24
|
Fiscal Period: February |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
|
6,450
|
7,164
|
11,359
|
10,469
|
8,644
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.051
x
|
0.9731
x
|
1.712
x
|
1.403
x
|
1.077
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
759
|
-2,935
|
2,042
|
3,467
|
2,770
|
3,320
|
2,900
|
ROE (net income / shareholders' equity)
|
14.1%
|
13.9%
|
11.3%
|
11.3%
|
12.1%
|
11.7%
|
11.3%
|
-
|
ROA (Net income/ Total Assets)
|
6.84%
|
9.57%
|
7.15%
|
7.72%
|
8.12%
|
8.8%
|
9%
|
-
|
Assets
1 |
45,613
|
34,376
|
41,463
|
41,979
|
47,088
|
46,591
|
48,889
|
-
|
Book Value Per Share
2 |
1,123
|
1,268
|
1,395
|
1,528
|
1,700
|
1,883
|
2,082
|
-
|
Cash Flow per Share
|
271.0
|
288.0
|
281.0
|
308.0
|
339.0
|
-
|
-
|
-
|
Capex
1 |
4,865
|
4,255
|
6,017
|
4,364
|
2,161
|
4,000
|
4,000
|
4,700
|
Capex / Sales
|
4.77%
|
3.85%
|
5%
|
3.39%
|
1.52%
|
2.68%
|
2.53%
|
-
|
Announcement Date
|
06/04/20
|
05/04/21
|
05/04/22
|
05/04/23
|
05/04/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +6.02% | 351M | | -18.91% | 3.31B | | -10.55% | 2.98B | | +0.76% | 2.7B | | -10.57% | 2.15B | | -5.96% | 1.86B | | +18.11% | 1.48B | | -26.32% | 891M | | -52.72% | 542M | | -0.53% | 426M |
Retail - Drugs with Grocery
|